Leila Monjazebmarvdashti

I have been working in biotechnology since 2013, and my current position is as a postdoctoral researcher in the Pathology Department at the University of California, San Diego. My main focus now is Alzheimer's disease research, where I am working on a large NIH-funded project to understand the mechanisms of this disease and develop medications for use in different stages, from early stage to others. Throughout my career, I have worked on various biotechnology projects, including postbiotics and supplements, which represents a new aspect in the probiotic field. I also have extensive experience with microbiota research. One of my significant achievements was working on celiac disease, where I discovered an enzyme from a bacterial species that I recorded in the NCBI database under my name. We developed a product that celiac patients can use to help manage their condition. In my home country of Iran, I am a co-founder of a factory based on biotechnology products. Since moving to the United States in 2024, I have been working under the mentorship of Steven Elgano, Chief of the Department of Pathology at UCSD, from whom I have learned a great deal. I am currently waiting for my green card and plan to eventually transfer my biotechnology work into a startup here in the United States, with the goal of establishing a factory to produce our products domestically.